Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery
- 1 June 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 165 (2-3) , 231-239
- https://doi.org/10.1016/0014-2999(89)90717-6
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Pinacidil inhibits insulin release by increasing K+ outflow from pancreatic B-cellsEuropean Journal of Pharmacology, 1988
- Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandilEuropean Journal of Pharmacology, 1988
- Studies on the mechanism of the vasodilator action of nicorandilLife Sciences, 1988
- Similarities in the Mechanism of Action of Two New Vasodilator Drugs: Pinacidil and BRL 34915Journal of Cardiovascular Pharmacology, 1988
- The pharmacology of potassium channels and their therapeutic potentialTrends in Pharmacological Sciences, 1988
- Comparison of the inhibitory effects of nicorandil, nitroglycerin and isosorbide dinitrate on vascular smooth muscle of rabbit aortaEuropean Journal of Pharmacology, 1987
- Tetraethylammonium ions and the potassium permeability of excitable cellsPublished by Springer Nature ,1983
- The aminopyridinesGeneral Pharmacology: The Vascular System, 1982
- Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitriteCanadian Journal of Physiology and Pharmacology, 1981
- N″-cyano-N-4-pyridyl-N′-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): A new, potent vasodilatorCellular and Molecular Life Sciences, 1980